Browse > Article
http://dx.doi.org/10.4014/mbl.1809.09007

Hepatitis E Virus Inhibits Activation of Signaling Molecules Involved in Induction of Type I Interferon  

Myoung, Jinjong (Korea Zoonosis Research Institute, Chonbuk National University)
Publication Information
Microbiology and Biotechnology Letters / v.46, no.4, 2018 , pp. 320-325 More about this Journal
Abstract
Hepatitis E virus (HEV) infection accounts for 20 million annual infections worldwide. HEV can be fatal in approximately 20-30% of pregnant women. HEV infections are normally self-limiting and mostly asymptomatic. However, in patients with insufficient immunity, such as acquired immunodeficiency syndrome patients, chronic and often fatal infections may ensue. Therefore, it is likely that host immune responses, especially interferon responses, play a critical role in HEV infection control. Here, we report that an HEV-encoded non-structural protein down-regulates type I interferon response. In addition, some other immune genes involved in the induction of type I interferon may be regulated as well. Detailed molecular mechanisms are currently being studied.
Keywords
Hepatitis E virus; type I interferon; protease;
Citations & Related Records
Times Cited By KSCI : 9  (Citation Analysis)
연도 인용수 순위
1 Forni D, Cagliani R, Clerici M, Sironi M. 2018. Origin and dispersal of Hepatitis E virus. Emerg. Microbes. Infect. 7: 11.
2 Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120-131.   DOI
3 Kang S, Choi C, Choi I, Han KN, Roh SW, Choi J, et al. 2018. Hepatitis E Virus Methyltransferase Inhibits Type I Interferon Induction by Targeting RIG-I. J. Microbiol. Biotechnol. 28: 1554-1562.
4 Kang S, Myoung J. 2017. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms. J. Microbiol. Biotechnol. 27: 1727-1735.   DOI
5 Kim N, Now H, Nguyen NTH, Yoo JY. 2016. Multilayered regulations of RIG-I in the anti-viral signaling pathway. J. Microbiol. 54: 583-587.   DOI
6 Schmidt ME, Varga SM. 2017. Modulation of the host immune response by respiratory syncytial virus proteins. J. Microbiol. 55: 161-171.   DOI
7 Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (${\alpha}$/${\beta}$) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.   DOI
8 Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. 2015. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15: 405-414.   DOI
9 Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345.   DOI
10 Takeuchi OandAkira S. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.   DOI
11 Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988.   DOI
12 Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347: aaa2630.   DOI
13 Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-${\kappa}B$ and IRF 3. Cell. 122: 669-682.   DOI
14 Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, et al. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76: 5532-5539.   DOI
15 Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.   DOI
16 Wi J, Jeong MS, Hong HJ. 2017. Construction and characterization of an Anti-Hepatitis B Virus preS1 humanized antibody that binds to the essential receptor binding site. J. Microbiol. Biotechnol. 27: 1336-1344.   DOI
17 Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, et al. 2003. IFN-${\alpha}$ antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 17: 488-490.   DOI
18 Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102: 2992-2997.   DOI
19 Kang SM, Won SJ, Lee GH, Lim YS, Hwang SB. 2010. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment. FEBS Lett. 584: 4069-4076.   DOI
20 Lan KH, Lan KL, Lee WP, Sheu ML, Chen MY, Lee YL, et al. 2007. HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines. J. Hepatol. 46: 759-767.
21 Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad.Sci. USA 102: 17717-17722.   DOI
22 Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, et al. 2006. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 80: 9226-9235.   DOI
23 Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285: 107-110.   DOI
24 Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. 2007. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol. 22: 676-682.   DOI
25 Navaneethan U, Al Mohajer M, Shata MT. 2008. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28: 1190-1199.   DOI
26 Krain LJ, Nelson KE, Labrique AB. 2014. Host immune status and response to hepatitis E virus infection. Clin. Microbiol. Rev. 27: 139-165.   DOI
27 Oshiumi H, Miyashita M, Matsumoto M, Seya T. 2013. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9: e1003533.   DOI
28 Zhou X, Xu L, Wang W, Watashi K, Wang Y, Sprengers D, et al. 2016. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection. J. Viral Hepat. 23: 294-304.   DOI
29 Karpe YA, Lole KS. 2011. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92: 2088-2092.   DOI
30 Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ. 2014. Hepatitis E virus inhibits type I interferon induction by ORF1 products. J. Virol. 88: 11924-11932.   DOI
31 Choi S, Park H, Minelko M, Kim EK, Cho MR, Nam JH. 2017. Recombinant adeno-associated virus expressing truncated IK cytokine diminishes the symptoms of inflammatory arthritis. J. Microbiol. Biotechnol. 27: 1892-1895.   DOI
32 Hamid FB, Kim J, Shin CG. 2017. Characterization of prototype foamy virus infectivity in transportin 3 knockdown human 293t cell line. J. Microbiol. Biotechnol. 27: 380-387.   DOI
33 Kim MJ, Lee SY, Kim HJ, Lee JS, Joo IS, Kwak HS, et al. 2016. Development of a one-step duplex RT-PCR method for the simultaneous detection of VP3/VP1 and VP1/P2B regions of the Hepatitis A Virus. J. Microbiol. Biotechnol. 26: 1398-1403.   DOI
34 Lee JM, Cho JB, Ahn HC, Jung W, Jeong YJ. 2017. A novel chemical compound for inhibition of SARS coronavirus helicase. J. Microbiol. Biotechnol. 27: 2070-2073.   DOI
35 Jeong H, Seong BL. 2017. Exploiting virus-like particles as innovative vaccines against emerging viral infections. J. Microbiol. 55: 220-230.   DOI
36 Lee JM, Kim J, Ryu I, Woo HM, Lee TG, Jung W, et al. 2017. An aptamer-based electrochemical sensor that can distinguish influenza virus subtype H1 from H5. J Microbiol Biotechnol. 27: 2037-2043.   DOI
37 Lim S, Cha S, Jang JH, Yang D, Choe J, Seo T. 2016. Alterations in acetylation of histone H4 Lysine 8 and trimethylation of lysine 20 associated with lytic gene promoters during Kaposi's sarcoma-associated herpesvirus reactivation. J. Microbiol. Biotechnol. 27: 189-196.
38 Elkholy YS, Hegab AS, Ismail DK, Hassan RM. 2016. Evaluation of a novel commercial quaternary ammonium compound for eradication of mycobacteria, HCV and HBV in egypt. J. Microbiol. 54: 39-43.   DOI
39 Kim JH, Lee CH, Lee SW. 2016. Hepatitis C virus infection stimulates transforming growth factor-${\beta}1$ expression through upregulating miR-192. J. Microbiol. 54: 520-526.   DOI
40 Shin JS, Ku KB, Jang Y, Yoon YS, Shin D, Kwon OS, et al. 2017. Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate. J. Microbiol. 55: 979-983.   DOI